Pharmaceutical company says reported Adderall shortage to be resolved 'in the coming weeks'
Some pharmacies have reported trouble stocking the common drug.
The Facts Inside Our Reporter’s Notebook
A major pharmaceutical company said this week that the reported shortage of Adderall throughout the country should be resolved in the coming weeks as it works through the labor shortage that brought about the supply hiccups.
Teva Pharmaceuticals told NBC News that it expects "full recovery for all inventory and orders in the coming weeks, at which point we expect no disruption at the pharmacy level." The company blamed "a labor shortage on its packaging line," the news network reported.
Pharmacies across the country have in recent weeks been reporting trouble stocking the drug, which is used to treat attention deficit disorder in many patients.
Hundreds of independent pharmacies in a recent survey reported difficulty acquiring the drug for patients, though national chain CVS said it was "not experiencing supply issues for Adderall," while Walgreens likewise claimed that "current supply is meeting our patient needs at this time," NBC reported.
Just News, No Noise
- Judge sides with DeSantis, says governor won’t have to testify in suit brought by prosecutor
- IRS warns taxpayers of new $600 threshold for reporting third-party payments
- House GOP leadership rejects 6 of 8 rules changes sought by conservatives, with more pending
- Musk indicates he will release internal Twitter docs on censorship of Hunter Biden laptop story
- Budweiser plans to send unsold beer intended for World Cup in Qatar to winning country